Eric Chen
Podiatrist · Phoenix, AZNPI 1023514619
Payments from drug & device makers
What this record shows
18 manufacturers reported payments, led by Pinnacle, Inc at 54.5% of the total. Reporting peaked in 2019 at $1,536 and has fallen 94.1% since, to $90 in 2025.
Across 30 payments — averaging $85.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pinnacle, Inc$1K
- Stryker$318
- Smith+Nephew$144
- Zimmer Biomet$131
- Amniox Medical, Inc.$92
- Misonix Inc$78
- plus $397 from 12 others
What the payments were for
- Food & beverage$1,16045%
- Education$1,39255%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pinnacle, Inc | 1 | $1,392 |
| Stryker | 8 | $318 |
| Smith+Nephew | 2 | $144 |
| Zimmer Biomet | 1 | $131 |
| Amniox Medical, Inc. | 1 | $92 |
| Misonix Inc | 1 | $78 |
| Acumed LLC | 1 | $70 |
| Johnson & Johnson(2 entities) | 3 | $60 |
| Bioventus LLC | 2 | $42 |
| Orthofix Medical, Inc. | 2 | $40 |
| Globus Medical | 1 | $39 |
| Biopro, Inc. | 1 | $31 |
| Reprise Biomedical, Inc. | 1 | $30 |
| Impactortho, Inc. | 1 | $22 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Abbott | 1 | $15 |
| Acell, Inc. | 1 | $15 |
| Averitas Pharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- A.L.P.S.$131
- RENASYS GO$119
How this compares
$2,552 in reported general payments places this provider in the 75th percentile of 151 podiatrist providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 23 | $230 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Phoenix
- Socorro MontesPhoenix$12K
- Timothy SekoskyPhoenix$5K
- Richard RandPhoenix$5K
- Gregory LooPhoenix$4K
- Ryan GolubPhoenix$4K
- Ryan PinedoPhoenix$4K
- Suzanne AbrahamPhoenix$4K
- Michael SekoskyPhoenix$3K
- John HarlanPhoenix$3K
- Seth ClarkPhoenix$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.